Financial Ratios

SHUKRA PHARMACEUTICALS LTD.

NSE : NABSE : 524632ISIN CODE : INE551C01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE72.005.61 (+8.45 %)
PREV CLOSE ( ) 66.39
OPEN PRICE ( ) 67.89
BID PRICE (QTY) 70.14 (100)
OFFER PRICE (QTY) 72.00 (38)
VOLUME 216692
TODAY'S LOW / HIGH ( )67.50 73.02
52 WK LOW / HIGH ( ) 25.59129.9
NSE
This Company is not listed in NSE
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)16.9411.264.791.200.23
   CEPS(Rs)4.703.990.800.550.50
   DPS(Rs)1.000.500.500.000.00
   Book NAV/Share(Rs)52.6764.63104.4399.6398.43
   Tax Rate(%)6.770.7926.26-92.3379.16
Margin Ratios
   Core EBITDA Margin(%)26.029.1214.0912.9011.22
   EBIT Margin(%)27.058.036.371.171.26
   Pre Tax Margin(%)26.667.554.970.871.24
   PAT Margin (%)24.867.493.661.680.26
   Cash Profit Margin (%)27.6110.6111.7814.8411.02
Performance Ratios
   ROA(%)24.268.012.120.540.11
   ROE(%)44.7021.164.701.210.23
   ROCE(%)44.2418.855.790.540.77
   Asset Turnover(x)0.981.070.580.320.44
   Sales/Fixed Asset(x)1.841.580.600.340.46
   Working Capital/Sales(x)1.775.575.861.241.84
Efficiency Ratios
   Fixed Capital/Sales(x)0.540.631.672.912.19
   Receivable days133.87116.60152.77288.50176.69
   Inventory Days13.3922.0650.2050.0122.02
   Payable days167.55170.00245.53761.94562.70
Valuation Parameters
   PER(x)4.821.042.627.7142.79
   PCE(x)17.362.943.924.194.84
   Price/Book(x)6.200.730.580.450.47
   Yield(%)0.311.070.830.000.00
   EV/Net Sales(x)4.700.330.611.451.29
   EV/Core EBITDA(x)15.782.974.239.029.84
   EV/EBIT(x)17.384.129.61123.8388.17
   EV/CE(x)5.770.640.640.640.65
   M Cap / Sales4.790.310.460.620.62
Growth Ratio
   Net Sales Growth(%)26.75187.1982.97-5.49109.31
   Core EBITDA Growth(%)238.70121.1264.8116.13-8.15
   EBIT Growth(%)327.07261.99895.12-24.17-76.15
   PAT Growth(%)320.68486.99299.10428.31-92.29
   EPS Growth(%)50.47134.80299.10428.30-92.29
Financial Stability Ratios
   Total Debt/Equity(x)0.050.200.210.630.52
   Current Ratio(x)3.971.251.282.282.07
   Quick Ratio(x)3.811.170.962.041.87
   Interest Cover(x)70.7716.824.553.9484.02
   Total Debt/Mcap(x)0.010.100.361.401.10

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.